Corticostatin for Injection can play a role in the treatment of collagenous diseases such as rheumatoid arthritis, active rheumatism, erythematous lupus; as well as allergic diseases such as severe bronchial asthma, severe dermatitis and acute leukemia, Hodgkin’s lymphoma. Injectable corticotropin is a hormone drug, which can increase the synthesis and secretion of adrenocorticotropic hormone in the patient’s body, thus it is effective in many collagenous diseases, such as rheumatoid arthritis, active rheumatism, erythematous lupus, and so on. It is also effective in some allergic diseases, such as severe bronchial asthma, severe dermatitis, and acute leukemia and Hodgkin’s lymphoma. Prolonged use of corticotropin for injection may cause adverse reactions such as medical Cushing’s syndrome, significant sodium retention, considerable loss of potassium, hyperpigmentation, allergy. It is contraindicated in people who are allergic to this drug, and is used with caution in pregnant and breastfeeding women, as well as in the presence of hypertension, tuberculosis, septic or mycobacterial infections, diabetes mellitus, gastric and duodenal ulcers, heart failure, and other diseases. As a prescription drug, medication must be used in strict accordance with medical advice.